Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Harmony Biosciences Holdings (HRMY) Return on Equity (2020 - 2025)

Harmony Biosciences Holdings' Return on Equity history spans 6 years, with the latest figure at 0.19% for Q4 2025.

  • For Q4 2025, Return on Equity fell 7.0% year-over-year to 0.19%; the TTM value through Dec 2025 reached 0.19%, down 7.0%, while the annual FY2025 figure was 0.21%, 8.0% down from the prior year.
  • Return on Equity for Q4 2025 was 0.19% at Harmony Biosciences Holdings, down from 0.25% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.53% in Q3 2022 and bottomed at 0.08% in Q3 2021.
  • The 5-year median for Return on Equity is 0.24% (2023), against an average of 0.23%.
  • The largest annual shift saw Return on Equity soared 59bps in 2021 before it crashed -39bps in 2023.
  • A 5-year view of Return on Equity shows it stood at 0.2% in 2021, then grew by 25bps to 0.25% in 2022, then rose by 7bps to 0.27% in 2023, then dropped by -5bps to 0.26% in 2024, then fell by -28bps to 0.19% in 2025.
  • Per Business Quant, the three most recent readings for HRMY's Return on Equity are 0.19% (Q4 2025), 0.25% (Q3 2025), and 0.26% (Q2 2025).